Formulation notes on where supplements are going.
Category deep-dives, emerging ingredients, and the manufacturing decisions that sit behind them — written by the people who quote and produce these SKUs every week.
Supplement Manufacturer MOQs: A Startup Founder's Guide to Minimum Order Quantities
MOQs are the single biggest source of sticker shock for supplement startups. Here's how minimums actually get set for capsules, tablets, and powders — and where the low-MOQ options live at our facility.
UV Shield Supplements: What's Actually in the Ingredient Deck
So-called 'UV shield' or 'inside-out sunscreen' supplements are one of the fastest-growing categories of 2026. Here's what we're seeing across formulas we quote.
Creatine Monohydrate Is Having Its Second Wave — Here's the Formulator's View
Creatine monohydrate is back at the top of the trends list — this time driven by cognitive and longevity claims rather than gym use. We break down what that means for capsule, tablet, and powder briefs.
NAD+ Precursors in 2026: NMN, NR, and Where the Category Is Going
NMN's regulatory status in the U.S. remains contested. Here's how brands are structuring product lines with NR, niacinamide, and combination stacks in the meantime.
The Gut-Brain Axis Category: Why Postbiotics Are Overtaking Probiotics
Postbiotics — non-living bacterial metabolites — are stabilizing the gut-brain axis category. They're easier to manufacture, easier to ship, and easier to make claims about.
Capsule or Tablet? A Formulator's Decision Tree
The capsule-versus-tablet decision is usually made on brand instinct. It should be made on the ingredient deck, dose weight, and unit-cost target. Here's how we walk brands through it.
Powder Supplement Flavoring & Sweetener Selection: A Formulator's Guide
Flavor and sweetener choices make or break a custom powder supplement. Here's how natural and artificial flavor systems, sweetener stability, and manufacturing compatibility affect the final blend.
Ready to manufacture your formula?
Send us your spec — capsule, tablet, or powder. We'll respond with a quote and next steps.